Chang, M.-C.; Chen, C.-T.; Chiang, P.-F.; Tang, I.-C.; Peng, C.-L.; Wang, Y.-F.; Tai, Y.-J.; Chiang, Y.-C.
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors. Int. J. Mol. Sci. 2025, 26, 6565.
https://doi.org/10.3390/ijms26146565
AMA Style
Chang M-C, Chen C-T, Chiang P-F, Tang I-C, Peng C-L, Wang Y-F, Tai Y-J, Chiang Y-C.
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors. International Journal of Molecular Sciences. 2025; 26(14):6565.
https://doi.org/10.3390/ijms26146565
Chicago/Turabian Style
Chang, Ming-Cheng, Chun-Tang Chen, Ping-Fang Chiang, I-Chung Tang, Cheng-Liang Peng, Yuh-Feng Wang, Yi-Jou Tai, and Ying-Cheng Chiang.
2025. "Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors" International Journal of Molecular Sciences 26, no. 14: 6565.
https://doi.org/10.3390/ijms26146565
APA Style
Chang, M.-C., Chen, C.-T., Chiang, P.-F., Tang, I.-C., Peng, C.-L., Wang, Y.-F., Tai, Y.-J., & Chiang, Y.-C.
(2025). Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors. International Journal of Molecular Sciences, 26(14), 6565.
https://doi.org/10.3390/ijms26146565
